139 related articles for article (PubMed ID: 28317862)
1. Biological Activity of Masked Endotoxin.
Schwarz H; Gornicec J; Neuper T; Parigiani MA; Wallner M; Duschl A; Horejs-Hoeck J
Sci Rep; 2017 Mar; 7():44750. PubMed ID: 28317862
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery.
Gorman A; Golovanov AP
Eur J Pharm Biopharm; 2022 Nov; 180():289-307. PubMed ID: 36272656
[TBL] [Abstract][Full Text] [Related]
3. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon.
Correa W; Brandenburg K; Zähringer U; Ravuri K; Khan T; von Wintzingerode F
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258200
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay.
Schromm AB; Correa W; Gisch N; Steiniger F; Richter W; Martinez-de-Tejada G; Brandenburg K; von Wintzingerode F
Biomed Pharmacother; 2024 Apr; 173():116286. PubMed ID: 38401515
[TBL] [Abstract][Full Text] [Related]
5. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems.
Reich J; Lang P; Grallert H; Motschmann H
Biologicals; 2016 Sep; 44(5):417-22. PubMed ID: 27464990
[TBL] [Abstract][Full Text] [Related]
6. Effect of different sample treatment methods on Low Endotoxin Recovery Phenomenon.
Bu R; Deng X; Cao Y; Jin J; Mai B; Meng K; Liu X; Chi JC; Zhang Y; Qiu F
J Microbiol Methods; 2021 Jul; 186():106241. PubMed ID: 33992679
[TBL] [Abstract][Full Text] [Related]
7. Sample Treatments That Solve Low Endotoxin Recovery Issues.
Tsuchiya M
PDA J Pharm Sci Technol; 2019; 73(5):433-442. PubMed ID: 30902837
[TBL] [Abstract][Full Text] [Related]
8. It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study.
Bolden J; Knight M; Montz J; One J; Stockman S; Jones SP
Biologicals; 2024 Jun; 87():101779. PubMed ID: 38908364
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the kinetics and mechanism of low endotoxin recovery in a matrix for biopharmaceutical drug products.
Reich J; Tamura H; Nagaoka I; Motschmann H
Biologicals; 2018 May; 53():1-9. PubMed ID: 29685804
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin detection--from limulus amebocyte lysate to recombinant factor C.
Ding JL; Ho B
Subcell Biochem; 2010; 53():187-208. PubMed ID: 20593268
[TBL] [Abstract][Full Text] [Related]
11. Factors Affecting Reduction of Reference Endotoxin Standard Activity Caused by Chelating Agent/Detergent Matrices: Kinetic Analysis of Low Endotoxin Recovery.
Tsuchiya M
PDA J Pharm Sci Technol; 2017; 71(6):478-487. PubMed ID: 28928294
[TBL] [Abstract][Full Text] [Related]
12. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells.
Schwarz H; Schmittner M; Duschl A; Horejs-Hoeck J
PLoS One; 2014; 9(12):e113840. PubMed ID: 25478795
[TBL] [Abstract][Full Text] [Related]
13. The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects.
Gnauck A; Lentle RG; Kruger MC
J Immunol Methods; 2015 Jan; 416():146-56. PubMed ID: 25433222
[TBL] [Abstract][Full Text] [Related]
14. The release and detection of endotoxin from liposomes.
Harmon P; Cabral-Lilly D; Reed RA; Maurio FP; Franklin JC; Janoff A
Anal Biochem; 1997 Aug; 250(2):139-46. PubMed ID: 9245430
[TBL] [Abstract][Full Text] [Related]
15. Evidence against a bacterial endotoxin masking effect in biologic drug products by limulus amebocyte lysate detection.
Bolden JS; Claerbout ME; Miner MK; Murphy MA; Smith KR; Warburton RE
PDA J Pharm Sci Technol; 2014; 68(5):472-7. PubMed ID: 25336418
[TBL] [Abstract][Full Text] [Related]
16. Low Endotoxin Recovery-Masking of Naturally Occurring Endotoxin.
Reich J; Weyer FA; Tamura H; Nagaoka I; Motschmann H
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781342
[TBL] [Abstract][Full Text] [Related]
17. A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samples.
Battin C; Hennig A; Mayrhofer P; Kunert R; Zlabinger GJ; Steinberger P; Paster W
PLoS One; 2017; 12(5):e0178220. PubMed ID: 28542462
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin recovery using limulus amebocyte lysate (LAL) assay.
Bolden JS; Warburton RE; Phelan R; Murphy M; Smith KR; De Felippis MR; Chen D
Biologicals; 2016 Sep; 44(5):434-40. PubMed ID: 27470947
[TBL] [Abstract][Full Text] [Related]
19. Human endothelial cell-based assay for endotoxin as sensitive as the conventional Limulus Amebocyte Lysate assay.
Unger RE; Peters K; Sartoris A; Freese C; Kirkpatrick CJ
Biomaterials; 2014 Mar; 35(10):3180-7. PubMed ID: 24456607
[TBL] [Abstract][Full Text] [Related]
20. Role of endotoxin in the expression of human monocyte cytotoxicity.
Biondi A; Peri G; Lorenzet R; Fumarola D; Mantovani A
J Reticuloendothel Soc; 1983 Apr; 33(4):315-27. PubMed ID: 6187919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
